(Q38201702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Post-acute management of the acquired long QT syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Sérgio Barra

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sharad Agarwal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

David Begley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

English

0 references

publication date

2 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

Postgraduate Medical Journal

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

1064

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

348-358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

Frequency of high-risk use of QT-prolonging medications

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Repolarization reserve: a moving target

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Electrocardiographic QT interval and mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Drug-induced torsades de pointes: the evolving role of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Genetics of acquired long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Influence of endogenous oestrogens on QT interval duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Long QT syndrome: reduced repolarization reserve and the genetic link

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Cardiac pacing in the long QT syndrome: review of available data and practical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Precision of QT interval measurement by advanced electrocardiographic equipment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

In-hospital prescription of QT-prolonging drugs in a cohort of more than 100,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European S

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2013-132398

10.1136/POSTGRADMEDJ-2013-132398

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696523%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference